Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 30, 2026
ExxonMobil (XOM): Q1 Earnings Preview with +29% YTD Gains and Upstream Tailwinds in Focus

ExxonMobil (XOM): Q1 Earnings Preview with +29% YTD Gains and Upstream Tailwinds in Focus

Key Takeaways

  • Analysts forecast Q1 earnings per share (EPS) of $1.01, down 42.6% from $1.76 in Q1 2025.
  • Consensus revenue estimate stands at $85.29 billion, up slightly from $83.13 billion year-over-year.
  • Company outlook highlights higher liquids prices adding $1.9-$2.3 billion in upstream earnings, offset by Middle East disruptions and timing effects in energy products.
  • Investors focus on production volumes, refining margins, and updates on Guyana and Permian Basin growth.
  • XOM shares have risen 29% year-to-date as of late April, trading around $155.
  • Historical post-earnings moves show downside in 9 of last 12 reports.

Earnings Context and Why It Matters

As XOM prepares to release its Q1 2026 earnings on May 1, the timing aligns with volatile oil prices and escalating geopolitical tensions in the Middle East. In my view, the integrated oil major has capitalized on robust upstream performance and disciplined cost management, contributing to shares climbing nearly 30% year-to-date on the back of sustained energy demand. Refining margins have softened, however, and planned maintenance along with regional disruptions present headwinds. This report stands out for investors like me who are monitoring the company's path to record production targets in basins such as the Permian and Guyana, while assessing the strength of downstream operations. Broader dynamics—including OPEC+ decisions and global supply chains—further elevate its relevance for positioning in the energy sector.

Earnings Expectations

Wall Street expects Q1 EPS of $1.01 on revenue of $85.29 billion, marking lower profitability compared to Q1 2025's $1.76 EPS and $83.13 billion in sales, according to 19 analysts. The Zacks Consensus is in line at $1.07 EPS.

From the company's April 8 outlook relative to Q4 2025, upstream earnings could increase by $1.1-$2.9 billion, driven by higher liquids prices ($1.9-$2.3B) and gas prices, though offset by Middle East volume impacts (-$0.5-$0.3B) and downtime. Energy Products anticipates a $4.2-$4.6 billion headwind from timing effects and maintenance (-$0.6-$0.4B). Chemical margins are projected to decline by $0.4-$0.2 billion. Overall, EPS should come in higher than Q4 excluding identified timing items, which are expected to reverse later in the year.

One thing that stands out are the key metrics: Permian output targeting over 20% growth, Guyana ramp-up, post-maintenance refining utilization, and free cash flow generation. XOM has a track record of frequently beating EPS estimates, though stock reactions have been mixed. I also checked peers using Tickeron’s AI Screener to contextualize these figures.

Market Reaction and Investor Sentiment

Sentiment heading into earnings feels balanced to me—optimism around upstream drivers tempered by caution on refining pressures and disruptions. XOM shares have benefited from crude price recovery, but history indicates post-earnings downside in 75% of the last 12 quarters. Implied volatility points to a potential 4-5% move. On the risk side, weaker volumes or downward guidance revisions could weigh on the stock; conversely, production beats might drive upside.

A Tool That's Helped My Analysis: Tickeron’s AI Screener

In my own research process, I frequently use Tickeron’s AI Screener, an AI-powered stock and ETF discovery tool that filters the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of stocks and ETFs with customizable criteria like industry, market cap, technical indicators, price patterns, and performance metrics, helping me pinpoint trade ideas, trending names, breakouts, and opportunities more efficiently than manual screening. If you're looking to streamline your stock analysis, it's a practical addition to the toolkit.

Forward Outlook and Key Factors to Monitor

I'll be paying close attention to Q1 guidance on full-year 2026, particularly any reaffirmation of $27-29 billion in cash capex directed toward high-return projects. XOM aims for structural earnings growth via Permian expansion—targeting over 1 million barrels per day oil equivalent—and the Guyana Payara Phase 2 startup, which should add low-cost barrels.

Refining margins continue to face oversupply pressures, while chemicals depend on economic rebound. Upstream production reached records last year; Q2 maintenance effects and OPEC+ supply cues will be in focus. Shareholder returns persist through $4-5 billion in quarterly buybacks, backed by a solid balance sheet.

Longer term, I'm watching low-emission investments and carbon capture advancements amid energy transition shifts. Key catalysts ahead include Q2 results and initial Guyana cargoes.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: XOM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for XOM turns positive, indicating new upward trend

XOM saw its Momentum Indicator move above the 0 level on August 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for XOM just turned positive on August 10, 2026. Looking at past instances where XOM's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

XOM moved above its 50-day moving average on July 17, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for XOM crossed bullishly above the 50-day moving average on July 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOM advanced for three days, in of 370 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 313 cases where XOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOM broke above its upper Bollinger Band on August 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XOM's P/B Ratio (2.618) is slightly higher than the industry average of (1.932). P/E Ratio (21.250) is within average values for comparable stocks, (16.808). Projected Growth (PEG Ratio) (1.292) is also within normal values, averaging (1.314). Dividend Yield (0.025) settles around the average of (0.037) among similar stocks. P/S Ratio (1.931) is also within normal values, averaging (3.587).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 123.86B. The market cap for tickers in the group ranges from 39.76K to 678.92B. XOM holds the highest valuation in this group at 678.92B. The lowest valued company is PGAS at 39.76K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 20%. PBR experienced the highest price growth at 7%, while SLNG experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 53
Price Growth Rating: 43
SMR Rating: 64
Profit Risk Rating: 27
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
XOM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a distributer of crude oil, natural gas and petroleum products

Industry IntegratedOil

Profile
Details
Industry
Integrated Oil
Address
22777 Springwoods Village Parkway
Phone
+1 972 940-6000
Employees
61500
Web
https://www.exxonmobil.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.